Track topics on Twitter Track topics that are important to you
Vetter is a leading contract development and manufacturing organization (CDMO) that specializes in the aseptic filling of syringes, cartridges and vials. The company has extensive experience with biologics and other complex compounds, including monoclonal antibodies, peptides, interferons and vaccines. Collaborating with pharma/biotech clients worldwide, Vetter supports products from preclinical development through global market supply. Through its U.S. and European facilities, Vetter Development Service provides state-of-the-art support for early-stage products, with seamless transfer at Phase III to Vetter Commercial Manufacturing for large-scale production. The company offers state-of-the-art technology and innovative processes to promote product quality and maximize API yield.
Vetter service divisions
Vetter Development Service
At Vetter Development Service (VDS), we partner with our clients from preclinical development through Phase III. Because we plan for commercial production from a product’s earliest stages, we develop processes that mirror those at our commercial production facilities. That enables seamless product transfer at Phase III to Vetter Commercial Manufacturing for scale-up and large-scale production. With a growing need for early-stage support in North America, in 2011 we expanded Vetter Development Service to Chicago, Vetter’s first U.S. facility. Vetter Development Service provides:
Vetter Commercial Manufacturing
Vetter Commercial Manufacturing provides Phase III clinical manufacturing through global market supply, featuring:
To strengthen security of supply, we take active steps both downstream and upstream to maintain the integrity of the supply chain, including regular quality reviews of all suppliers and cross-linked IT systems to monitor manufacturing processes. Vetter manufactures products for the top 10 pharma/biotech firms worldwide.
Vetter Packaging Solutions
Vetter Packaging Solutions helps clients match their product with the appropriate drug-delivery system (primary packaging); secondary packaging, such as cartoning or blister packing; and packaging services, such as pen-system assembly. Vetter Packaging Solutions provides:
For US inquiries please contact +1-847-581-6888 or infoUS@vetter-pharma.com.
Vetter has begun an expansion of its secondary packaging capacities that will increase its facility by approximately 32,000 square feet.
Vetter has begun construction on a new administration building following a â100m ($107m) investment earlier this year to expand its visual inspection and logistics center.
Company establishes its presence in South Korea Additional footprint in Asia Pacific region New office underlines company’s commitment to its cu...
Ravensburg, Germany, September 28, 2017 / B3C newswire / -- At a cornerstone ceremony, Vetter officially signaled the start of a project for the creation of a new administration building at its ...
Fill and finish CDMO Vetter says its newly opened sales office in Songdo will tap the large Korean biologics market.
Vetter has opened a new branch office in the biologics cluster in Songdo, South Korea, as part of its continued efforts to strengthen its global footprint in the Asia Pacific (APAC) region.
Global pre-filled drug delivery systems company and packaging expert, Vetter, is expanding its secondary packaging capacity in response to rising customer needs and market demands.
Vetter, one of the global leaders in prefilled drug─delivery systems, announced the official opening of a new branch office in South Korea. The new office in Songdo is located within the biologics c...
PURAX Pure Pads Anti-Perspirant Spray
PURAX Pure Pads Anti-Perspirant Roll-On
Package.Label Principle Display Panel
Fluoride Chewable Tablets 0.5 mg
We would like to respond to Scott et al. and the accompanying editorial.(1,2) Concentrated factor products like recombinant activated factor VII (NovoSeven(®) , Novo Nordisk Pharmaceuticals Inc.) an...
After two decades of focused development and some recent clinical successes, cell and gene therapy (CGT) is emerging as a promising approach to personalized medicines. Genetically engineered cells as ...
An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...
Bioequivalence Study of Daclatasvir From Prodactariv 60 mg Film Coated Tablets (International Drug Agency for Pharmaceutical Industry (IDI), Egypt) and Clatazev 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)
An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Daclatasvir from Prodactariv 60 mg F.C.T (International Drug Agency for Pha...
The purpose of this study is to confirm a significant influence of ezetimibe and sirolimus on each others pharmacokinetics
This study are two-way crossover, open-label, single-dose, fasting, bioequivalence study of Memantinol® (JSC "GEROPHARM", Russia) 20 mg tablets versus Akatinol Memantine® (Merz Pharma Gm...
- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...
Vetter is a leading contract development and manufacturing organization (CDMO) that specializes in the aseptic filling of syringes, cartridges and vials. The company has extensive experience with bi...
Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...
INJEX Pharma Aktiengesellschaft and its subsidiaries INJEX Pharma GmbH and INJEX Vertrieb Deutschland GmbH are specialized in the development, manufacturing and marketing in the m...
CROMA-PHARMA is a family owned, internationally orientated pharmaceutical company, based in Korneuburg, Austria. CROMA-PHARMAÂ´s areas of activity are orthopedics, ophthalmology...
Ormecon GmbH, with its location in Ammersbek/Germany, is the headquarter of Ormecon International. Ormecon GmbH was originally founded as "Ormecon Chemie GmbH & Co. KG" in 1996, as a 100% subsidiary o...
We have published hundreds of Vetter Pharma International GmbH news stories on BioPortfolio along with dozens of Vetter Pharma International GmbH Clinical Trials and PubMed Articles about Vetter Pharma International GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vetter Pharma International GmbH Companies in our database. You can also find out about relevant Vetter Pharma International GmbH Drugs and Medications on this site too.
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...